Acurx Pharmaceuticals
White Plains
About Acurx Pharmaceuticals
Acurx Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing new antibiotics for difficult to treat infections. The Company's approach is to develop antibiotic candidates that target the DNA polymerase IIIC enzyme and its R&D pipeline includes early stage antibiotic candidates that target other Gram-positive bacteria, including Methicillin-Resistant Staphylococcus aureus (MRSA), Vancomycin-Resistant Enterococcus (VRE) and Penicillin-Resistant Streptococcus pneumoniae (PRSP).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $11.7M
- Funding stage: IPO
- Last round: Grant (Nov 2025)
- Ticker: nasdaq:ACXP
- Website: acurxpharma.com
Industries & Categories
Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/acurx-pharmaceuticals-106387 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.